Despite our use of a composite clinical-functional outcome measure, we could not consistently assess other relevant clinical and functional endpoints, such as fatigue, sleep and mood disturbance, and specific cognitive sequelae, which may have had particular relevance to patients with anti-LGI1 Ab-mediated encephalitis. The gene discussed is LGI1; the disease is encephalitis.